nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—SLCO3A1—Methotrexate—systemic lupus erythematosus	0.308	0.765	CbGbCtD
Alprostadil—ABCC4—Methotrexate—systemic lupus erythematosus	0.0947	0.235	CbGbCtD
Alprostadil—PTGIR—endothelium—systemic lupus erythematosus	0.00909	0.0674	CbGeAlD
Alprostadil—Epoprostenol—P2RY12—systemic lupus erythematosus	0.00828	0.867	CrCbGaD
Alprostadil—PTGIR—blood plasma—systemic lupus erythematosus	0.00807	0.0598	CbGeAlD
Alprostadil—PTGER1—kidney—systemic lupus erythematosus	0.00592	0.0439	CbGeAlD
Alprostadil—PTGER2—tendon—systemic lupus erythematosus	0.00505	0.0374	CbGeAlD
Alprostadil—PTGER2—bone marrow—systemic lupus erythematosus	0.00489	0.0362	CbGeAlD
Alprostadil—ABCC4—blood plasma—systemic lupus erythematosus	0.00447	0.0332	CbGeAlD
Alprostadil—PTGER2—lung—systemic lupus erythematosus	0.00443	0.0328	CbGeAlD
Alprostadil—PTGIR—connective tissue—systemic lupus erythematosus	0.0043	0.0319	CbGeAlD
Alprostadil—PTGER1—nervous system—systemic lupus erythematosus	0.00389	0.0288	CbGeAlD
Alprostadil—PTGER1—central nervous system—systemic lupus erythematosus	0.00374	0.0277	CbGeAlD
Alprostadil—PTGIR—kidney—systemic lupus erythematosus	0.00366	0.0271	CbGeAlD
Alprostadil—SLCO2A1—nephron tubule—systemic lupus erythematosus	0.00364	0.027	CbGeAlD
Alprostadil—SLCO2A1—skin of body—systemic lupus erythematosus	0.00339	0.0251	CbGeAlD
Alprostadil—ABCC5—nephron tubule—systemic lupus erythematosus	0.00333	0.0247	CbGeAlD
Alprostadil—SLCO3A1—kidney—systemic lupus erythematosus	0.00323	0.0239	CbGeAlD
Alprostadil—SLCO2A1—kidney—systemic lupus erythematosus	0.0032	0.0237	CbGeAlD
Alprostadil—SLCO3A1—cortex of kidney—systemic lupus erythematosus	0.00315	0.0233	CbGeAlD
Alprostadil—SLCO2A1—cortex of kidney—systemic lupus erythematosus	0.00312	0.0231	CbGeAlD
Alprostadil—SLCO3A1—tendon—systemic lupus erythematosus	0.00261	0.0193	CbGeAlD
Alprostadil—PTGIR—lung—systemic lupus erythematosus	0.00259	0.0192	CbGeAlD
Alprostadil—SLCO2A1—tendon—systemic lupus erythematosus	0.00258	0.0191	CbGeAlD
Alprostadil—PTGIR—nervous system—systemic lupus erythematosus	0.0024	0.0178	CbGeAlD
Alprostadil—ABCC5—tendon—systemic lupus erythematosus	0.00236	0.0175	CbGeAlD
Alprostadil—PTGIR—central nervous system—systemic lupus erythematosus	0.00231	0.0171	CbGeAlD
Alprostadil—ABCC4—nephron tubule—systemic lupus erythematosus	0.00231	0.0171	CbGeAlD
Alprostadil—SLCO2B1—kidney—systemic lupus erythematosus	0.00229	0.017	CbGeAlD
Alprostadil—SLCO3A1—lung—systemic lupus erythematosus	0.00229	0.017	CbGeAlD
Alprostadil—ABCC5—bone marrow—systemic lupus erythematosus	0.00229	0.017	CbGeAlD
Alprostadil—SLCO2A1—lung—systemic lupus erythematosus	0.00227	0.0168	CbGeAlD
Alprostadil—SLCO3A1—nervous system—systemic lupus erythematosus	0.00212	0.0157	CbGeAlD
Alprostadil—SLCO2A1—nervous system—systemic lupus erythematosus	0.0021	0.0156	CbGeAlD
Alprostadil—ABCC5—lung—systemic lupus erythematosus	0.00207	0.0154	CbGeAlD
Alprostadil—SLCO3A1—central nervous system—systemic lupus erythematosus	0.00204	0.0151	CbGeAlD
Alprostadil—ABCC4—kidney—systemic lupus erythematosus	0.00203	0.015	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—systemic lupus erythematosus	0.00202	0.015	CbGeAlD
Alprostadil—ABCC4—cortex of kidney—systemic lupus erythematosus	0.00197	0.0146	CbGeAlD
Alprostadil—SLCO2B1—tendon—systemic lupus erythematosus	0.00185	0.0137	CbGeAlD
Alprostadil—ABCC4—tendon—systemic lupus erythematosus	0.00164	0.0121	CbGeAlD
Alprostadil—SLCO2B1—lung—systemic lupus erythematosus	0.00162	0.012	CbGeAlD
Alprostadil—ABCC4—bone marrow—systemic lupus erythematosus	0.00159	0.0118	CbGeAlD
Alprostadil—SLCO2B1—nervous system—systemic lupus erythematosus	0.0015	0.0111	CbGeAlD
Alprostadil—SLCO2B1—central nervous system—systemic lupus erythematosus	0.00145	0.0107	CbGeAlD
Alprostadil—ABCC4—lung—systemic lupus erythematosus	0.00144	0.0107	CbGeAlD
Alprostadil—ABCC4—nervous system—systemic lupus erythematosus	0.00133	0.00986	CbGeAlD
Alprostadil—ABCC4—central nervous system—systemic lupus erythematosus	0.00128	0.0095	CbGeAlD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—systemic lupus erythematosus	0.00127	0.133	CrCbGaD
Alprostadil—Back pain—Triamcinolone—systemic lupus erythematosus	0.000312	0.000928	CcSEcCtD
Alprostadil—Loss of consciousness—Prednisolone—systemic lupus erythematosus	0.000308	0.000917	CcSEcCtD
Alprostadil—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000308	0.000916	CcSEcCtD
Alprostadil—Syncope—Hydrocortisone—systemic lupus erythematosus	0.000307	0.000914	CcSEcCtD
Alprostadil—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000307	0.000913	CcSEcCtD
Alprostadil—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000306	0.000909	CcSEcCtD
Alprostadil—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000305	0.000907	CcSEcCtD
Alprostadil—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.000304	0.000905	CcSEcCtD
Alprostadil—Convulsion—Prednisolone—systemic lupus erythematosus	0.000304	0.000904	CcSEcCtD
Alprostadil—Hypertension—Prednisolone—systemic lupus erythematosus	0.000303	0.000901	CcSEcCtD
Alprostadil—Shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000302	0.000898	CcSEcCtD
Alprostadil—Loss of consciousness—Hydrocortisone—systemic lupus erythematosus	0.000301	0.000896	CcSEcCtD
Alprostadil—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000301	0.000894	CcSEcCtD
Alprostadil—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.0003	0.000891	CcSEcCtD
Alprostadil—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000298	0.000887	CcSEcCtD
Alprostadil—Bradycardia—Prednisone—systemic lupus erythematosus	0.000298	0.000887	CcSEcCtD
Alprostadil—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000297	0.000883	CcSEcCtD
Alprostadil—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000297	0.000883	CcSEcCtD
Alprostadil—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000296	0.00088	CcSEcCtD
Alprostadil—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000296	0.000879	CcSEcCtD
Alprostadil—Discomfort—Prednisolone—systemic lupus erythematosus	0.000295	0.000878	CcSEcCtD
Alprostadil—Haemoglobin—Prednisone—systemic lupus erythematosus	0.000294	0.000876	CcSEcCtD
Alprostadil—Haemorrhage—Prednisone—systemic lupus erythematosus	0.000293	0.000871	CcSEcCtD
Alprostadil—Erythema—Dexamethasone—systemic lupus erythematosus	0.000293	0.000871	CcSEcCtD
Alprostadil—Erythema—Betamethasone—systemic lupus erythematosus	0.000293	0.000871	CcSEcCtD
Alprostadil—Asthenia—Leflunomide—systemic lupus erythematosus	0.000293	0.00087	CcSEcCtD
Alprostadil—Syncope—Triamcinolone—systemic lupus erythematosus	0.000289	0.000861	CcSEcCtD
Alprostadil—Syncope—Methylprednisolone—systemic lupus erythematosus	0.000289	0.000859	CcSEcCtD
Alprostadil—Pruritus—Leflunomide—systemic lupus erythematosus	0.000289	0.000858	CcSEcCtD
Alprostadil—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000288	0.000857	CcSEcCtD
Alprostadil—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000287	0.000853	CcSEcCtD
Alprostadil—Oedema—Prednisolone—systemic lupus erythematosus	0.000286	0.000852	CcSEcCtD
Alprostadil—Dizziness—Azathioprine—systemic lupus erythematosus	0.000286	0.000849	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000284	0.000845	CcSEcCtD
Alprostadil—Loss of consciousness—Triamcinolone—systemic lupus erythematosus	0.000284	0.000844	CcSEcCtD
Alprostadil—Loss of consciousness—Methylprednisolone—systemic lupus erythematosus	0.000283	0.000842	CcSEcCtD
Alprostadil—Shock—Prednisolone—systemic lupus erythematosus	0.000282	0.000838	CcSEcCtD
Alprostadil—Cough—Triamcinolone—systemic lupus erythematosus	0.000282	0.000838	CcSEcCtD
Alprostadil—Oedema—Hydrocortisone—systemic lupus erythematosus	0.00028	0.000832	CcSEcCtD
Alprostadil—Convulsion—Triamcinolone—systemic lupus erythematosus	0.00028	0.000832	CcSEcCtD
Alprostadil—Tachycardia—Prednisolone—systemic lupus erythematosus	0.00028	0.000831	CcSEcCtD
Alprostadil—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000279	0.00083	CcSEcCtD
Alprostadil—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000279	0.00083	CcSEcCtD
Alprostadil—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000279	0.000829	CcSEcCtD
Alprostadil—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000278	0.000827	CcSEcCtD
Alprostadil—Infection—Hydrocortisone—systemic lupus erythematosus	0.000278	0.000826	CcSEcCtD
Alprostadil—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000277	0.000824	CcSEcCtD
Alprostadil—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000277	0.000823	CcSEcCtD
Alprostadil—Shock—Hydrocortisone—systemic lupus erythematosus	0.000275	0.000818	CcSEcCtD
Alprostadil—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000273	0.000812	CcSEcCtD
Alprostadil—Rash—Azathioprine—systemic lupus erythematosus	0.000272	0.00081	CcSEcCtD
Alprostadil—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000272	0.000809	CcSEcCtD
Alprostadil—Flushing—Prednisone—systemic lupus erythematosus	0.000272	0.000809	CcSEcCtD
Alprostadil—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000272	0.000808	CcSEcCtD
Alprostadil—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000271	0.000807	CcSEcCtD
Alprostadil—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000271	0.000806	CcSEcCtD
Alprostadil—Headache—Azathioprine—systemic lupus erythematosus	0.000271	0.000805	CcSEcCtD
Alprostadil—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.00027	0.000804	CcSEcCtD
Alprostadil—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.00027	0.000804	CcSEcCtD
Alprostadil—Dizziness—Leflunomide—systemic lupus erythematosus	0.00027	0.000802	CcSEcCtD
Alprostadil—Pain—Cyclosporine—systemic lupus erythematosus	0.000269	0.0008	CcSEcCtD
Alprostadil—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000269	0.000799	CcSEcCtD
Alprostadil—Renal failure—Methotrexate—systemic lupus erythematosus	0.000268	0.000797	CcSEcCtD
Alprostadil—Oedema—Triamcinolone—systemic lupus erythematosus	0.000263	0.000783	CcSEcCtD
Alprostadil—Syncope—Dexamethasone—systemic lupus erythematosus	0.000263	0.000781	CcSEcCtD
Alprostadil—Syncope—Betamethasone—systemic lupus erythematosus	0.000263	0.000781	CcSEcCtD
Alprostadil—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000263	0.000781	CcSEcCtD
Alprostadil—Infection—Triamcinolone—systemic lupus erythematosus	0.000262	0.000778	CcSEcCtD
Alprostadil—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000261	0.000777	CcSEcCtD
Alprostadil—Infection—Methylprednisolone—systemic lupus erythematosus	0.000261	0.000776	CcSEcCtD
Alprostadil—Haematuria—Methotrexate—systemic lupus erythematosus	0.00026	0.000773	CcSEcCtD
Alprostadil—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000259	0.000771	CcSEcCtD
Alprostadil—Shock—Triamcinolone—systemic lupus erythematosus	0.000259	0.000771	CcSEcCtD
Alprostadil—Shock—Methylprednisolone—systemic lupus erythematosus	0.000259	0.000769	CcSEcCtD
Alprostadil—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000257	0.000765	CcSEcCtD
Alprostadil—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000257	0.000765	CcSEcCtD
Alprostadil—Rash—Leflunomide—systemic lupus erythematosus	0.000257	0.000765	CcSEcCtD
Alprostadil—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000257	0.000764	CcSEcCtD
Alprostadil—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000257	0.000764	CcSEcCtD
Alprostadil—Nausea—Azathioprine—systemic lupus erythematosus	0.000257	0.000763	CcSEcCtD
Alprostadil—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000257	0.000763	CcSEcCtD
Alprostadil—Headache—Leflunomide—systemic lupus erythematosus	0.000256	0.00076	CcSEcCtD
Alprostadil—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000255	0.000759	CcSEcCtD
Alprostadil—Erythema—Prednisone—systemic lupus erythematosus	0.000255	0.000758	CcSEcCtD
Alprostadil—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000255	0.000757	CcSEcCtD
Alprostadil—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000254	0.000756	CcSEcCtD
Alprostadil—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000254	0.000755	CcSEcCtD
Alprostadil—Convulsion—Betamethasone—systemic lupus erythematosus	0.000254	0.000755	CcSEcCtD
Alprostadil—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000253	0.000752	CcSEcCtD
Alprostadil—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000253	0.000752	CcSEcCtD
Alprostadil—Hypertension—Betamethasone—systemic lupus erythematosus	0.000253	0.000752	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000252	0.00217	CbGpPWpGaD
Alprostadil—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000249	0.00074	CcSEcCtD
Alprostadil—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000249	0.00074	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000248	0.00214	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000248	0.00214	CbGpPWpGaD
Alprostadil—Discomfort—Betamethasone—systemic lupus erythematosus	0.000246	0.000733	CcSEcCtD
Alprostadil—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000246	0.000733	CcSEcCtD
Alprostadil—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000246	0.000732	CcSEcCtD
Alprostadil—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000246	0.000732	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—C3—systemic lupus erythematosus	0.000246	0.00212	CbGpPWpGaD
Alprostadil—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000246	0.00073	CcSEcCtD
Alprostadil—Pain—Prednisolone—systemic lupus erythematosus	0.000245	0.000728	CcSEcCtD
Alprostadil—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000245	0.000728	CcSEcCtD
Alprostadil—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000243	0.000723	CcSEcCtD
Alprostadil—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000243	0.000722	CcSEcCtD
Alprostadil—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000243	0.000722	CcSEcCtD
Alprostadil—Nausea—Leflunomide—systemic lupus erythematosus	0.000242	0.00072	CcSEcCtD
Alprostadil—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.00024	0.000714	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	0.000239	0.00206	CbGpPWpGaD
Alprostadil—Pain—Hydrocortisone—systemic lupus erythematosus	0.000239	0.000711	CcSEcCtD
Alprostadil—Oedema—Dexamethasone—systemic lupus erythematosus	0.000239	0.000711	CcSEcCtD
Alprostadil—Oedema—Betamethasone—systemic lupus erythematosus	0.000239	0.000711	CcSEcCtD
Alprostadil—Infection—Dexamethasone—systemic lupus erythematosus	0.000237	0.000706	CcSEcCtD
Alprostadil—Infection—Betamethasone—systemic lupus erythematosus	0.000237	0.000706	CcSEcCtD
Alprostadil—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000236	0.000702	CcSEcCtD
Alprostadil—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000236	0.000702	CcSEcCtD
Alprostadil—Anaemia—Prednisone—systemic lupus erythematosus	0.000236	0.000701	CcSEcCtD
Alprostadil—Shock—Dexamethasone—systemic lupus erythematosus	0.000235	0.000699	CcSEcCtD
Alprostadil—Shock—Betamethasone—systemic lupus erythematosus	0.000235	0.000699	CcSEcCtD
Alprostadil—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000234	0.000696	CcSEcCtD
Alprostadil—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000234	0.000696	CcSEcCtD
Alprostadil—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000233	0.000694	CcSEcCtD
Alprostadil—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000233	0.000694	CcSEcCtD
Alprostadil—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000232	0.00069	CcSEcCtD
Alprostadil—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000231	0.000688	CcSEcCtD
Alprostadil—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000231	0.000687	CcSEcCtD
Alprostadil—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000231	0.000687	CcSEcCtD
Alprostadil—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000231	0.000686	CcSEcCtD
Alprostadil—Syncope—Prednisone—systemic lupus erythematosus	0.000229	0.00068	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—ITGAX—systemic lupus erythematosus	0.000228	0.00196	CbGpPWpGaD
Alprostadil—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000226	0.000672	CcSEcCtD
Alprostadil—Pain—Triamcinolone—systemic lupus erythematosus	0.000225	0.00067	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—F3—systemic lupus erythematosus	0.000224	0.00193	CbGpPWpGaD
Alprostadil—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000224	0.000667	CcSEcCtD
Alprostadil—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000223	0.000664	CcSEcCtD
Alprostadil—Hypotension—Betamethasone—systemic lupus erythematosus	0.000223	0.000664	CcSEcCtD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000223	0.00192	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000223	0.00192	CbGpPWpGaD
Alprostadil—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000223	0.000662	CcSEcCtD
Alprostadil—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000221	0.000658	CcSEcCtD
Alprostadil—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000221	0.000658	CcSEcCtD
Alprostadil—Convulsion—Prednisone—systemic lupus erythematosus	0.000221	0.000657	CcSEcCtD
Alprostadil—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00022	0.000655	CcSEcCtD
Alprostadil—Hypertension—Prednisone—systemic lupus erythematosus	0.00022	0.000655	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000218	0.00188	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000218	0.00188	CbGpPWpGaD
Alprostadil—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000217	0.000646	CcSEcCtD
Alprostadil—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000217	0.000645	CcSEcCtD
Alprostadil—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000217	0.000644	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—F2—systemic lupus erythematosus	0.000216	0.00186	CbGpPWpGaD
Alprostadil—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000215	0.00064	CcSEcCtD
Alprostadil—Discomfort—Prednisone—systemic lupus erythematosus	0.000215	0.000638	CcSEcCtD
Alprostadil—Erythema—Methotrexate—systemic lupus erythematosus	0.000213	0.000634	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—IFNA1—systemic lupus erythematosus	0.000212	0.00183	CbGpPWpGaD
Alprostadil—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.00021	0.000626	CcSEcCtD
Alprostadil—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.00021	0.000626	CcSEcCtD
Alprostadil—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00021	0.000625	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000209	0.0018	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000208	0.00179	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000208	0.00179	CbGpPWpGaD
Alprostadil—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000208	0.000619	CcSEcCtD
Alprostadil—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000208	0.000619	CcSEcCtD
Alprostadil—Oedema—Prednisone—systemic lupus erythematosus	0.000208	0.000619	CcSEcCtD
Alprostadil—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000208	0.000618	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000208	0.00179	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000207	0.00178	CbGpPWpGaD
Alprostadil—Infection—Prednisone—systemic lupus erythematosus	0.000207	0.000615	CcSEcCtD
Alprostadil—Back pain—Methotrexate—systemic lupus erythematosus	0.000206	0.000613	CcSEcCtD
Alprostadil—Shock—Prednisone—systemic lupus erythematosus	0.000205	0.000609	CcSEcCtD
Alprostadil—Pain—Betamethasone—systemic lupus erythematosus	0.000204	0.000608	CcSEcCtD
Alprostadil—Pain—Dexamethasone—systemic lupus erythematosus	0.000204	0.000608	CcSEcCtD
Alprostadil—Tachycardia—Prednisone—systemic lupus erythematosus	0.000203	0.000604	CcSEcCtD
Alprostadil—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000203	0.000604	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—CLU—systemic lupus erythematosus	0.000203	0.00175	CbGpPWpGaD
Alprostadil—Skin disorder—Prednisone—systemic lupus erythematosus	0.000202	0.000601	CcSEcCtD
Alprostadil—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000201	0.000598	CcSEcCtD
Alprostadil—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000201	0.000597	CcSEcCtD
Alprostadil—Rash—Cyclosporine—systemic lupus erythematosus	0.000198	0.00059	CcSEcCtD
Alprostadil—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000198	0.00059	CcSEcCtD
Alprostadil—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000198	0.000589	CcSEcCtD
Alprostadil—Headache—Cyclosporine—systemic lupus erythematosus	0.000197	0.000586	CcSEcCtD
Alprostadil—Anaemia—Methotrexate—systemic lupus erythematosus	0.000197	0.000586	CcSEcCtD
Alprostadil—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000197	0.000586	CcSEcCtD
Alprostadil—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000197	0.000586	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—P2RY12—systemic lupus erythematosus	0.000197	0.00169	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—CCL2—systemic lupus erythematosus	0.000196	0.00169	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—VEGFA—systemic lupus erythematosus	0.000195	0.00168	CbGpPWpGaD
Alprostadil—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000194	0.000576	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000194	0.00167	CbGpPWpGaD
Alprostadil—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000193	0.000575	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000193	0.00166	CbGpPWpGaD
Alprostadil—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000192	0.000572	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000192	0.00165	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000192	0.00165	CbGpPWpGaD
Alprostadil—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000191	0.000569	CcSEcCtD
Alprostadil—Dizziness—Prednisolone—systemic lupus erythematosus	0.000189	0.000563	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000189	0.00163	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000189	0.00163	CbGpPWpGaD
Alprostadil—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000189	0.000562	CcSEcCtD
Alprostadil—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000189	0.000562	CcSEcCtD
Alprostadil—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000189	0.000562	CcSEcCtD
Alprostadil—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000189	0.000562	CcSEcCtD
Alprostadil—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000189	0.000562	CcSEcCtD
Alprostadil—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000189	0.000561	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000188	0.00162	CbGpPWpGaD
Alprostadil—Nausea—Cyclosporine—systemic lupus erythematosus	0.000187	0.000556	CcSEcCtD
Alprostadil—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000186	0.000554	CcSEcCtD
Alprostadil—Cough—Methotrexate—systemic lupus erythematosus	0.000186	0.000553	CcSEcCtD
Alprostadil—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000186	0.000553	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	0.000186	0.0016	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	0.000185	0.0016	CbGpPWpGaD
Alprostadil—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000185	0.00055	CcSEcCtD
Alprostadil—Convulsion—Methotrexate—systemic lupus erythematosus	0.000185	0.000549	CcSEcCtD
Alprostadil—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000183	0.000545	CcSEcCtD
Alprostadil—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000182	0.000542	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—CSK—systemic lupus erythematosus	0.000181	0.00156	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SELE—systemic lupus erythematosus	0.000181	0.00156	CbGpPWpGaD
Alprostadil—Rash—Prednisolone—systemic lupus erythematosus	0.000181	0.000537	CcSEcCtD
Alprostadil—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00018	0.000537	CcSEcCtD
Alprostadil—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.00018	0.000535	CcSEcCtD
Alprostadil—Headache—Prednisolone—systemic lupus erythematosus	0.000179	0.000534	CcSEcCtD
Alprostadil—Discomfort—Methotrexate—systemic lupus erythematosus	0.000179	0.000533	CcSEcCtD
Alprostadil—ABCC4—Platelet degranulation—TGFB1—systemic lupus erythematosus	0.000179	0.00154	CbGpPWpGaD
Alprostadil—Rash—Hydrocortisone—systemic lupus erythematosus	0.000176	0.000525	CcSEcCtD
Alprostadil—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000176	0.000524	CcSEcCtD
Alprostadil—ABCC5—Disease—XRCC6—systemic lupus erythematosus	0.000176	0.00151	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000176	0.00151	CbGpPWpGaD
Alprostadil—Headache—Hydrocortisone—systemic lupus erythematosus	0.000175	0.000521	CcSEcCtD
Alprostadil—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000174	0.000518	CcSEcCtD
Alprostadil—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000174	0.000517	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	0.000173	0.00149	CbGpPWpGaD
Alprostadil—Infection—Methotrexate—systemic lupus erythematosus	0.000173	0.000514	CcSEcCtD
Alprostadil—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000172	0.00051	CcSEcCtD
Alprostadil—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000171	0.00051	CcSEcCtD
Alprostadil—Asthenia—Betamethasone—systemic lupus erythematosus	0.000171	0.00051	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000171	0.00147	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000171	0.00147	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000171	0.00147	CbGpPWpGaD
Alprostadil—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.00017	0.000506	CcSEcCtD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	0.00017	0.00146	CbGpPWpGaD
Alprostadil—Nausea—Prednisolone—systemic lupus erythematosus	0.00017	0.000506	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00017	0.00146	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00017	0.00146	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ITGAM—systemic lupus erythematosus	0.00017	0.00146	CbGpPWpGaD
Alprostadil—Pruritus—Betamethasone—systemic lupus erythematosus	0.000169	0.000503	CcSEcCtD
Alprostadil—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000169	0.000503	CcSEcCtD
Alprostadil—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000169	0.000502	CcSEcCtD
Alprostadil—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000168	0.0005	CcSEcCtD
Alprostadil—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000166	0.000494	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—C3—systemic lupus erythematosus	0.000166	0.00143	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—C3—systemic lupus erythematosus	0.000166	0.00143	CbGpPWpGaD
Alprostadil—Rash—Triamcinolone—systemic lupus erythematosus	0.000166	0.000494	CcSEcCtD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000166	0.00143	CbGpPWpGaD
Alprostadil—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000166	0.000493	CcSEcCtD
Alprostadil—Rash—Methylprednisolone—systemic lupus erythematosus	0.000166	0.000493	CcSEcCtD
Alprostadil—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000166	0.000492	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000165	0.00142	CbGpPWpGaD
Alprostadil—Headache—Triamcinolone—systemic lupus erythematosus	0.000165	0.000491	CcSEcCtD
Alprostadil—Headache—Methylprednisolone—systemic lupus erythematosus	0.000165	0.00049	CcSEcCtD
Alprostadil—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000165	0.000489	CcSEcCtD
Alprostadil—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000165	0.000489	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—LYN—systemic lupus erythematosus	0.000164	0.00141	CbGpPWpGaD
Alprostadil—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000164	0.000486	CcSEcCtD
Alprostadil—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000164	0.000486	CcSEcCtD
Alprostadil—Hypotension—Methotrexate—systemic lupus erythematosus	0.000163	0.000483	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—SH2B3—systemic lupus erythematosus	0.000161	0.00139	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—JAK1—systemic lupus erythematosus	0.00016	0.00138	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—TGFB1—systemic lupus erythematosus	0.000159	0.00137	CbGpPWpGaD
Alprostadil—Dizziness—Betamethasone—systemic lupus erythematosus	0.000158	0.00047	CcSEcCtD
Alprostadil—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000158	0.00047	CcSEcCtD
Alprostadil—Nausea—Triamcinolone—systemic lupus erythematosus	0.000156	0.000465	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000156	0.00135	CbGpPWpGaD
Alprostadil—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000156	0.000464	CcSEcCtD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	0.000154	0.00132	CbGpPWpGaD
Alprostadil—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000153	0.000455	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—CSK—systemic lupus erythematosus	0.000152	0.00131	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	0.000151	0.0013	CbGpPWpGaD
Alprostadil—Rash—Betamethasone—systemic lupus erythematosus	0.000151	0.000448	CcSEcCtD
Alprostadil—Rash—Dexamethasone—systemic lupus erythematosus	0.000151	0.000448	CcSEcCtD
Alprostadil—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000151	0.000448	CcSEcCtD
Alprostadil—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000151	0.000448	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.00015	0.00129	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IL2RA—systemic lupus erythematosus	0.00015	0.00129	CbGpPWpGaD
Alprostadil—Headache—Dexamethasone—systemic lupus erythematosus	0.00015	0.000445	CcSEcCtD
Alprostadil—Headache—Betamethasone—systemic lupus erythematosus	0.00015	0.000445	CcSEcCtD
Alprostadil—Asthenia—Prednisone—systemic lupus erythematosus	0.000149	0.000444	CcSEcCtD
Alprostadil—Pain—Methotrexate—systemic lupus erythematosus	0.000149	0.000442	CcSEcCtD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000149	0.00128	CbGpPWpGaD
Alprostadil—Pruritus—Prednisone—systemic lupus erythematosus	0.000147	0.000438	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—F2—systemic lupus erythematosus	0.000146	0.00126	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—F2—systemic lupus erythematosus	0.000146	0.00126	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	0.000146	0.00125	CbGpPWpGaD
Alprostadil—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000143	0.000426	CcSEcCtD
Alprostadil—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000142	0.000423	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000142	0.00122	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000142	0.00122	CbGpPWpGaD
Alprostadil—Nausea—Dexamethasone—systemic lupus erythematosus	0.000142	0.000422	CcSEcCtD
Alprostadil—Nausea—Betamethasone—systemic lupus erythematosus	0.000142	0.000422	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00014	0.00121	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00014	0.00121	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.00014	0.00121	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000139	0.0012	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000139	0.0012	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—LYN—systemic lupus erythematosus	0.000138	0.00119	CbGpPWpGaD
Alprostadil—Dizziness—Prednisone—systemic lupus erythematosus	0.000138	0.000409	CcSEcCtD
Alprostadil—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000138	0.000409	CcSEcCtD
Alprostadil—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000138	0.000409	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000136	0.00117	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000136	0.00117	CbGpPWpGaD
Alprostadil—Rash—Prednisone—systemic lupus erythematosus	0.000131	0.00039	CcSEcCtD
Alprostadil—Dermatitis—Prednisone—systemic lupus erythematosus	0.000131	0.00039	CcSEcCtD
Alprostadil—PTGER1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000131	0.00113	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000131	0.00113	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—F2—systemic lupus erythematosus	0.00013	0.00112	CbGpPWpGaD
Alprostadil—Headache—Prednisone—systemic lupus erythematosus	0.00013	0.000388	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.00013	0.00112	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.00013	0.00112	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HIST2H2AC—systemic lupus erythematosus	0.00013	0.00112	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000129	0.00111	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000127	0.0011	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000127	0.0011	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000127	0.0011	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IFNA1—systemic lupus erythematosus	0.000127	0.00109	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CSK—systemic lupus erythematosus	0.000126	0.00109	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—C3—systemic lupus erythematosus	0.000126	0.00109	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	0.000125	0.00108	CbGpPWpGaD
Alprostadil—Asthenia—Methotrexate—systemic lupus erythematosus	0.000125	0.000371	CcSEcCtD
Alprostadil—Nausea—Prednisone—systemic lupus erythematosus	0.000124	0.000368	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000123	0.00106	CbGpPWpGaD
Alprostadil—Pruritus—Methotrexate—systemic lupus erythematosus	0.000123	0.000366	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000122	0.00105	CbGpPWpGaD
Alprostadil—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000119	0.000354	CcSEcCtD
Alprostadil—ABCC5—Disease—CD247—systemic lupus erythematosus	0.000119	0.00102	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000119	0.00102	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000119	0.00102	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NAT2—systemic lupus erythematosus	0.000119	0.00102	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NCF2—systemic lupus erythematosus	0.000116	0.000994	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000115	0.000993	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000115	0.000993	CbGpPWpGaD
Alprostadil—Dizziness—Methotrexate—systemic lupus erythematosus	0.000115	0.000342	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000112	0.000962	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000112	0.000962	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000111	0.000958	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—F2—systemic lupus erythematosus	0.000111	0.000954	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—TGFB1—systemic lupus erythematosus	0.00011	0.00095	CbGpPWpGaD
Alprostadil—Rash—Methotrexate—systemic lupus erythematosus	0.00011	0.000326	CcSEcCtD
Alprostadil—Dermatitis—Methotrexate—systemic lupus erythematosus	0.00011	0.000326	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000109	0.000941	CbGpPWpGaD
Alprostadil—Headache—Methotrexate—systemic lupus erythematosus	0.000109	0.000324	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—ALB—systemic lupus erythematosus	0.000108	0.000933	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000106	0.000909	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000106	0.000909	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000104	0.000894	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—NOS3—systemic lupus erythematosus	0.000104	0.000892	CbGpPWpGaD
Alprostadil—Nausea—Methotrexate—systemic lupus erythematosus	0.000103	0.000307	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—CSK—systemic lupus erythematosus	0.000103	0.000885	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CSK—systemic lupus erythematosus	0.000103	0.000885	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	0.000102	0.000881	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	0.000102	0.000874	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000101	0.000873	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000101	0.000873	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PRL—systemic lupus erythematosus	0.000101	0.000867	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL2—systemic lupus erythematosus	9.88e-05	0.00085	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.85e-05	0.000848	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.61e-05	0.000827	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.61e-05	0.000827	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—JAK1—systemic lupus erythematosus	9.56e-05	0.000823	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.47e-05	0.000815	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.47e-05	0.000815	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NCF2—systemic lupus erythematosus	9.41e-05	0.00081	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NCF2—systemic lupus erythematosus	9.41e-05	0.00081	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—C3—systemic lupus erythematosus	9.39e-05	0.000808	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—C3—systemic lupus erythematosus	9.39e-05	0.000808	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LYN—systemic lupus erythematosus	9.35e-05	0.000804	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LYN—systemic lupus erythematosus	9.35e-05	0.000804	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.21e-05	0.000793	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.21e-05	0.000793	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.17e-05	0.000789	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.17e-05	0.000789	CbGpPWpGaD
Alprostadil—ABCC5—Disease—JUNB—systemic lupus erythematosus	9.07e-05	0.00078	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TYK2—systemic lupus erythematosus	8.97e-05	0.000772	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2RA—systemic lupus erythematosus	8.93e-05	0.000769	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IL2—systemic lupus erythematosus	8.79e-05	0.000756	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.73e-05	0.000751	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.73e-05	0.000751	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	8.63e-05	0.000743	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.6e-05	0.00074	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.6e-05	0.00074	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—C3—systemic lupus erythematosus	8.53e-05	0.000734	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—C3—systemic lupus erythematosus	8.53e-05	0.000734	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.44e-05	0.000726	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PRL—systemic lupus erythematosus	8.35e-05	0.000719	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—F2—systemic lupus erythematosus	8.24e-05	0.00071	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—F2—systemic lupus erythematosus	8.24e-05	0.00071	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL2—systemic lupus erythematosus	8.22e-05	0.000707	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.06e-05	0.000694	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—JAK1—systemic lupus erythematosus	8.05e-05	0.000693	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	7.92e-05	0.000682	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—EP300—systemic lupus erythematosus	7.88e-05	0.000679	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—F2—systemic lupus erythematosus	7.78e-05	0.000669	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR5—systemic lupus erythematosus	7.63e-05	0.000657	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.52e-05	0.000647	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.52e-05	0.000647	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.52e-05	0.000647	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—F2—systemic lupus erythematosus	7.49e-05	0.000644	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—F2—systemic lupus erythematosus	7.49e-05	0.000644	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—systemic lupus erythematosus	7.47e-05	0.000643	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2—systemic lupus erythematosus	7.46e-05	0.000642	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—C3—systemic lupus erythematosus	7.46e-05	0.000642	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JUNB—systemic lupus erythematosus	7.38e-05	0.000635	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JUNB—systemic lupus erythematosus	7.38e-05	0.000635	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.01e-05	0.000604	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.01e-05	0.000604	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TGFB1—systemic lupus erythematosus	6.85e-05	0.00059	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRL—systemic lupus erythematosus	6.8e-05	0.000585	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRL—systemic lupus erythematosus	6.8e-05	0.000585	CbGpPWpGaD
Alprostadil—ABCC5—Disease—JAK1—systemic lupus erythematosus	6.68e-05	0.000575	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.67e-05	0.000574	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.67e-05	0.000574	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—RXRA—systemic lupus erythematosus	6.65e-05	0.000573	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—F2—systemic lupus erythematosus	6.55e-05	0.000564	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ALB—systemic lupus erythematosus	6.46e-05	0.000556	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CCR5—systemic lupus erythematosus	6.33e-05	0.000545	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CD80—systemic lupus erythematosus	6.28e-05	0.00054	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—systemic lupus erythematosus	6.18e-05	0.000532	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.06e-05	0.000522	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.06e-05	0.000522	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL2—systemic lupus erythematosus	5.84e-05	0.000502	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.59e-05	0.000481	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.55e-05	0.000478	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.55e-05	0.000478	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JAK1—systemic lupus erythematosus	5.44e-05	0.000468	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JAK1—systemic lupus erythematosus	5.44e-05	0.000468	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TYK2—systemic lupus erythematosus	5.3e-05	0.000456	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2—systemic lupus erythematosus	5.24e-05	0.000451	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD80—systemic lupus erythematosus	5.21e-05	0.000448	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—systemic lupus erythematosus	5.2e-05	0.000448	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR5—systemic lupus erythematosus	5.15e-05	0.000444	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR5—systemic lupus erythematosus	5.15e-05	0.000444	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.08e-05	0.000437	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.08e-05	0.000437	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2—systemic lupus erythematosus	5.04e-05	0.000434	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2—systemic lupus erythematosus	5.04e-05	0.000434	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—C3—systemic lupus erythematosus	5.04e-05	0.000434	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—C3—systemic lupus erythematosus	5.04e-05	0.000434	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—EP300—systemic lupus erythematosus	4.7e-05	0.000404	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.51e-05	0.000388	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—systemic lupus erythematosus	4.45e-05	0.000383	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—F2—systemic lupus erythematosus	4.42e-05	0.000381	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—F2—systemic lupus erythematosus	4.42e-05	0.000381	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2—systemic lupus erythematosus	4.41e-05	0.00038	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TYK2—systemic lupus erythematosus	4.4e-05	0.000378	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—systemic lupus erythematosus	4.39e-05	0.000378	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—systemic lupus erythematosus	4.31e-05	0.000371	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CD80—systemic lupus erythematosus	4.24e-05	0.000365	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CD80—systemic lupus erythematosus	4.24e-05	0.000365	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARG—systemic lupus erythematosus	4.2e-05	0.000362	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—systemic lupus erythematosus	4.17e-05	0.000359	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.16e-05	0.000358	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB1—systemic lupus erythematosus	4.08e-05	0.000352	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CD4—systemic lupus erythematosus	3.98e-05	0.000342	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EP300—systemic lupus erythematosus	3.96e-05	0.000341	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—systemic lupus erythematosus	3.95e-05	0.00034	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL2—systemic lupus erythematosus	3.94e-05	0.000339	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL2—systemic lupus erythematosus	3.94e-05	0.000339	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—systemic lupus erythematosus	3.78e-05	0.000325	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.75e-05	0.000323	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1B—systemic lupus erythematosus	3.74e-05	0.000322	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—systemic lupus erythematosus	3.61e-05	0.000311	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TYK2—systemic lupus erythematosus	3.58e-05	0.000308	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TYK2—systemic lupus erythematosus	3.58e-05	0.000308	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—systemic lupus erythematosus	3.51e-05	0.000302	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—systemic lupus erythematosus	3.51e-05	0.000302	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1A—systemic lupus erythematosus	3.45e-05	0.000297	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.44e-05	0.000296	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—systemic lupus erythematosus	3.3e-05	0.000284	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EP300—systemic lupus erythematosus	3.28e-05	0.000282	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.04e-05	0.000262	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.04e-05	0.000262	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2—systemic lupus erythematosus	2.98e-05	0.000256	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2—systemic lupus erythematosus	2.98e-05	0.000256	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—systemic lupus erythematosus	2.96e-05	0.000255	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.96e-05	0.000255	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TGFB1—systemic lupus erythematosus	2.85e-05	0.000246	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—systemic lupus erythematosus	2.82e-05	0.000243	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.82e-05	0.000243	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.81e-05	0.000242	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.81e-05	0.000242	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—EP300—systemic lupus erythematosus	2.75e-05	0.000237	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EP300—systemic lupus erythematosus	2.67e-05	0.00023	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EP300—systemic lupus erythematosus	2.67e-05	0.00023	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—systemic lupus erythematosus	2.59e-05	0.000223	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.53e-05	0.000218	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.53e-05	0.000218	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.32e-05	0.0002	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.32e-05	0.0002	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—systemic lupus erythematosus	2.15e-05	0.000185	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—systemic lupus erythematosus	1.75e-05	0.000151	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—systemic lupus erythematosus	1.75e-05	0.000151	CbGpPWpGaD
